tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO

Compare Crescent Biopharma (CBIO) vs. Competitors

Compare
1,022 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Crescent Biopharma
$10.90
$300.37M
-8.24
-59.84%
5 Buy
0 Hold
0 Sell
Strong Buy
Compugen
$2.09
$197.62M
4.04
30.62%
2 Buy
0 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.10
$127.89M
-0.86
17.52%
0 Buy
4 Hold
0 Sell
Hold
Orchestra BioMed Holdings
$4.64
$271.54M
-3,008.78
6.67%
5 Buy
1 Hold
0 Sell
Strong Buy
Fractyl Health, Inc.
$0.44
$60.48M
-64.15%
3 Buy
1 Hold
0 Sell
Strong Buy
Actuate Therapeutics, Inc.
$2.35
$54.62M
-66.38%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CBIO
Crescent Biopharma
10.90
-15.47
-58.67%
CGEN
Compugen
2.09
0.47
29.01%
FATE
Fate Therapeutics
1.10
0.16
17.02%
OBIO
Orchestra BioMed Holdings
4.64
0.07
1.53%
GUTS
Fractyl Health, Inc.
0.44
-0.86
-66.08%
ACTU
Actuate Therapeutics, Inc.
2.35
-4.85
-67.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts